Amid the COVID-19 pandemic, New York State is here to provide resources, guidance, and support for certified programs to safety serve individuals and families while navigating the pandemic.
This guidance provides information on SARS-CoV-2 (COVID-19) POC Ag testing for New York State (NYS) Office of Addiction Services and Supports (OASAS) licensed, funded, and...
Preliminary guidance for reopening Opioid Treatment Program (OTP) services on a regional basis amid New York Forward and the evolving COVID-19 pandemic. (Updated 01/28/22)
Frequently Asked Questions for on providing and billing for OASAS telepractice services amid COVID-19 including rate codes for reimbursement. Issued May 12, 2020.
OASAS certified or authorized providers should submit a self-attestation for permission to utilize Telepractice during the COVID-19 emergency. Issued 3/20/20. Updated 5/12/20.
Billing guidance and updated rate codes for OTPs to ensure adequate reimbursement of services delivered after 3/16/20 and for the duration of the COVID-19 pandemic. Revised April 26...
Frequently asked questions and recommendations to support Opioid Treatment Programs (OTPs) operating in the wake of the evolving COVID-19 situation in New York State.
Patients may now be initiated on buprenorphine through the use of telepractice in accordance with DEA guidance that is in effect during the state of emergency.
The OASAS Division of Outcome Management and System Information provides daily updates of COVID-19 data for certified, community based, non-hospital bedded and outpatient programs.